Ascenta Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: Malvern PA United States (2003)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2005
NCT00275431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Ascenta Therapeutics, Inc.